Disc Historical Balance Sheet

IRON Stock

64.96 1.45 2.28%

Trend analysis of Disc Medicine balance sheet accounts such as Other Current Liabilities of 8.4 M or Total Current Liabilities of 16 M provides information on Disc Medicine's total assets, liabilities, and equity, which is the actual value of Disc Medicine to its prevalent stockholders. By breaking down trends over time using Disc Medicine balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Disc Medicine latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Disc Medicine is a good buy for the upcoming year.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Disc Medicine. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

To learn how to invest in Disc Stock, please use our How to Invest in Disc Medicine guide.

About Disc Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Disc Medicine at a specified time, usually calculated after every quarter, six months, or one year. Disc Medicine Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Disc Medicine and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Disc currently owns. An asset can also be divided into two categories, current and non-current.

Disc Medicine Balance Sheet Chart

At this time, Disc Medicine's Total Current Assets are very stable compared to the past year.

Short Long Term Debt Total Other Current Liab Total Current Liabilities Non Current Liabilities Total

Total Current Liabilities

Total Current Liabilities is an item on Disc Medicine balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Disc Medicine are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Disc Medicine's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Disc Medicine current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Disc Medicine. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

To learn how to invest in Disc Stock, please use our How to Invest in Disc Medicine guide.At this time, Disc Medicine's Total Current Assets are very stable compared to the past year.

	2021	2022	2023	2024 (projected)
Short and Long Term Debt Total	1.7M	1.3M	2.1M	2.0M
Total Assets	92.4M	200.2M	368.0M	215.2M

Short Long Term Debt Total Total Assets

Disc Medicine balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Short Long Term Debt	Total Current Assets	Capital Stock
Total Assets		-0.64	0.34	0.75	0.83	-0.58	0.72	-0.12	-0.87	-0.85	0.8	0.86	-0.64	-0.65	-0.65	0.86	0.79	-0.25	0.85	0.93	-0.03	0.98	0.8	-0.65	0.86	-0.65
Short Long Term Debt Total	-0.64		-0.81	-0.97	-0.39	1.0	-0.98	-0.57	0.89	0.91	-0.8	-0.87	1.0	1.0	1.0	-0.87	-0.53	-0.42	-0.94	-0.87	-0.66	-0.72	-0.96	0.99	-0.87	1.0
Other Current Liab	0.34	-0.81		0.67	0.06	-0.81	0.82	0.82	-0.64	-0.67	0.31	0.62	-0.82	-0.82	-0.82	0.62	0.47	0.77	0.67	0.6	0.91	0.49	0.79	-0.8	0.62	-0.82
Total Current Liabilities	0.75	-0.97	0.67		0.5	-0.96	0.97	0.41	-0.91	-0.93	0.91	0.89	-0.97	-0.97	-0.97	0.89	0.53	0.24	0.98	0.93	0.48	0.8	0.96	-0.97	0.89	-0.97
Total Stockholder Equity	0.83	-0.39	0.06	0.5		-0.33	0.42	-0.5	-0.76	-0.73	0.65	0.79	-0.4	-0.4	-0.41	0.79	0.86	-0.59	0.58	0.67	-0.34	0.77	0.52	-0.32	0.78	-0.4
Net Tangible Assets	-0.58	1.0	-0.81	-0.96	-0.33		-0.97	-0.61	0.86	0.88	-0.78	-0.83	1.0	1.0	0.99	-0.83	-0.47	-0.46	-0.92	-0.83	-0.69	-0.66	-0.93	0.98	-0.83	1.0
Property Plant And Equipment Net	0.72	-0.98	0.82	0.97	0.42	-0.97		0.55	-0.91	-0.93	0.79	0.88	-0.99	-0.99	-0.99	0.88	0.59	0.4	0.97	0.92	0.63	0.8	0.99	-0.99	0.88	-0.99
Current Deferred Revenue	-0.12	-0.57	0.82	0.41	-0.5	-0.61	0.55		-0.18	-0.23	0.04	0.14	-0.56	-0.56	-0.56	0.14	-0.12	0.98	0.35	0.22	0.98	0.03	0.45	-0.6	0.15	-0.56
Net Debt	-0.87	0.89	-0.64	-0.91	-0.76	0.86	-0.91	-0.18		1.0	-0.85	-1.0	0.9	0.9	0.9	-1.0	-0.83	-0.04	-0.95	-0.95	-0.33	-0.91	-0.95	0.85	-1.0	0.9
Retained Earnings	-0.85	0.91	-0.67	-0.93	-0.73	0.88	-0.93	-0.23	1.0		-0.85	-0.99	0.92	0.92	0.92	-0.99	-0.81	-0.08	-0.96	-0.95	-0.37	-0.9	-0.96	0.88	-0.99	0.92
Accounts Payable	0.8	-0.8	0.31	0.91	0.65	-0.78	0.79	0.04	-0.85	-0.85		0.83	-0.8	-0.8	-0.8	0.83	0.48	-0.15	0.89	0.88	0.1	0.77	0.8	-0.8	0.83	-0.8
Cash	0.86	-0.87	0.62	0.89	0.79	-0.83	0.88	0.14	-1.0	-0.99	0.83		-0.87	-0.88	-0.88	1.0	0.85	0.01	0.92	0.93	0.3	0.89	0.92	-0.82	1.0	-0.88
Non Current Assets Total	-0.64	1.0	-0.82	-0.97	-0.4	1.0	-0.99	-0.56	0.9	0.92	-0.8	-0.87		1.0	1.0	-0.87	-0.55	-0.41	-0.95	-0.88	-0.66	-0.72	-0.96	0.98	-0.88	1.0
Non Currrent Assets Other	-0.65	1.0	-0.82	-0.97	-0.4	1.0	-0.99	-0.56	0.9	0.92	-0.8	-0.88	1.0		1.0	-0.88	-0.55	-0.41	-0.95	-0.88	-0.66	-0.73	-0.96	0.98	-0.88	1.0
Long Term Debt	-0.65	1.0	-0.82	-0.97	-0.41	0.99	-0.99	-0.56	0.9	0.92	-0.8	-0.88	1.0	1.0		-0.88	-0.55	-0.41	-0.95	-0.88	-0.65	-0.73	-0.96	0.98	-0.88	1.0
Cash And Short Term Investments	0.86	-0.87	0.62	0.89	0.79	-0.83	0.88	0.14	-1.0	-0.99	0.83	1.0	-0.87	-0.88	-0.88		0.85	0.01	0.92	0.93	0.3	0.89	0.92	-0.82	1.0	-0.88
Common Stock Shares Outstanding	0.79	-0.53	0.47	0.53	0.86	-0.47	0.59	-0.12	-0.83	-0.81	0.48	0.85	-0.55	-0.55	-0.55	0.85		-0.16	0.64	0.72	0.07	0.82	0.68	-0.46	0.85	-0.55
Non Current Liabilities Total	-0.25	-0.42	0.77	0.24	-0.59	-0.46	0.4	0.98	-0.04	-0.08	-0.15	0.01	-0.41	-0.41	-0.41	0.01	-0.16		0.19	0.07	0.95	-0.09	0.31	-0.45	0.01	-0.41
Other Current Assets	0.85	-0.94	0.67	0.98	0.58	-0.92	0.97	0.35	-0.95	-0.96	0.89	0.92	-0.95	-0.95	-0.95	0.92	0.64	0.19		0.98	0.43	0.89	0.98	-0.95	0.92	-0.95
Other Stockholder Equity	0.93	-0.87	0.6	0.93	0.67	-0.83	0.92	0.22	-0.95	-0.95	0.88	0.93	-0.88	-0.88	-0.88	0.93	0.72	0.07	0.98		0.31	0.96	0.96	-0.89	0.93	-0.88
Total Liab	-0.03	-0.66	0.91	0.48	-0.34	-0.69	0.63	0.98	-0.33	-0.37	0.1	0.3	-0.66	-0.66	-0.65	0.3	0.07	0.95	0.43	0.31		0.14	0.55	-0.66	0.3	-0.66
Net Invested Capital	0.98	-0.72	0.49	0.8	0.77	-0.66	0.8	0.03	-0.91	-0.9	0.77	0.89	-0.72	-0.73	-0.73	0.89	0.82	-0.09	0.89	0.96	0.14		0.88	-0.73	0.89	-0.73
Property Plant And Equipment Gross	0.8	-0.96	0.79	0.96	0.52	-0.93	0.99	0.45	-0.95	-0.96	0.8	0.92	-0.96	-0.96	-0.96	0.92	0.68	0.31	0.98	0.96	0.55	0.88		-0.96	0.92	-0.96
Short Long Term Debt	-0.65	0.99	-0.8	-0.97	-0.32	0.98	-0.99	-0.6	0.85	0.88	-0.8	-0.82	0.98	0.98	0.98	-0.82	-0.46	-0.45	-0.95	-0.89	-0.66	-0.73	-0.96		-0.82	0.98
Total Current Assets	0.86	-0.87	0.62	0.89	0.78	-0.83	0.88	0.15	-1.0	-0.99	0.83	1.0	-0.88	-0.88	-0.88	1.0	0.85	0.01	0.92	0.93	0.3	0.89	0.92	-0.82		-0.88
Capital Stock	-0.65	1.0	-0.82	-0.97	-0.4	1.0	-0.99	-0.56	0.9	0.92	-0.8	-0.88	1.0	1.0	1.0	-0.88	-0.55	-0.41	-0.95	-0.88	-0.66	-0.73	-0.96	0.98	-0.88

Click cells to compare fundamentals

Disc Medicine Account Relationship Matchups

Pair Trading with Disc Medicine

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Disc Medicine position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Disc Medicine will appreciate offsetting losses from the drop in the long position's value.

Moving against Disc Stock

0.78	PFE	Pfizer Inc Aggressive Push	Pair Corr
0.76	TCHH	Trustcash Holdings	Pair Corr
0.73	JNJ	Johnson Johnson Sell-off Trend	Pair Corr
0.65	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.6	AGL	agilon health	Pair Corr

The ability to find closely correlated positions to Disc Medicine could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Disc Medicine when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Disc Medicine - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Disc Medicine to buy it.

The correlation of Disc Medicine is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Disc Medicine moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Disc Medicine moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Disc Medicine can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Disc Medicine offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Disc Medicine's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Disc Medicine Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Disc Medicine Stock:

How To Invest In Disc

Details

Is Disc Stock a good investment?

Details

What is Disc Medicine's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

To learn how to invest in Disc Stock, please use our How to Invest in Disc Medicine guide.

You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Disc Medicine. If investors know Disc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Disc Medicine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(3.95)

Return On Assets

(0.18)

Return On Equity

(0.25)

The market value of Disc Medicine is measured differently than its book value, which is the value of Disc that is recorded on the company's balance sheet. Investors also form their own opinion of Disc Medicine's value that differs from its market value or its book value, called intrinsic value, which is Disc Medicine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Disc Medicine's market value can be influenced by many factors that don't directly affect Disc Medicine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Disc Medicine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Disc Medicine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Disc Medicine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Disc Historical Balance Sheet

About Disc Balance Sheet Analysis

Disc Medicine Balance Sheet Chart

Total Current Liabilities

Disc Medicine balance sheet Correlations

Disc Medicine Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Pair Trading with Disc Medicine

Moving against Disc Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Tangible Assets	+ 1.0	Short Long Term Debt Total
Non Current Assets Total	+ 1.0	Short Long Term Debt Total
Non Currrent Assets Other	+ 1.0	Short Long Term Debt Total
Long Term Debt	+ 1.0	Short Long Term Debt Total
Capital Stock	+ 1.0	Short Long Term Debt Total
Non Current Assets Total	+ 1.0	Net Tangible Assets

Total Current Assets	- 1.0	Net Debt
Cash And Short Term Investments	- 1.0	Net Debt
Cash	- 1.0	Net Debt
Total Current Assets	- 0.99	Retained Earnings
Cash And Short Term Investments	- 0.99	Retained Earnings
Cash	- 0.99	Retained Earnings